Search Results
Results found for "pain modeling"
- Dr. Kenneth A. Jacobson | Dr. GPCR Ecosystem
He adapts interdisciplinary approaches (synthesis, modeling, pharmacology) to study G protein-coupled
- Dr. Graham Ladds | Dr. GPCR Ecosystem
His research group uses a combination of pharmacological investigations and mathematical modeling to
- Dr. Benjamin Myers | Dr. GPCR Ecosystem
transmembrane receptors, combining biochemical and structural approaches with cell biology and in vivo models
- Dr. Marta Filizola | Dr. GPCR Ecosystem
computational structural biology tools and rational drug design approaches, ranging from molecular modeling
- Developing new tools to uncover GPCR signaling patterns with Remi Janicot | Dr. GPCR Ecosystem
Overall, the lab works on diverse models and diseases, and has developed a wide array of tools to dissect
- Dr. Nicola J. Smith | Dr. GPCR Ecosystem
the understanding of how an orphan GPCR exerts its effects both in vitro (cell culture and ex vivo models
- Annette Gilchrist: Native Cell Systems, Biased Agonism, and the Pharmacogenomics Gap | Dr. GPCR Ecosystem
much as a confirmation - if you look in the right system, receptors show you things overexpression models SCIENTIFIC THEMES OF THE CONVERSATION The native cell argument - why overexpression models produce systematically you screen in determines the biology you can find Running a GPCR screen in a HEK cell overexpression model direct product of that discipline - a result that would have been invisible in a standard overexpression model had already won their Nobel Prize 12:39 Co-founding CUE Biotech and Caden Biosciences - allosteric modulator
- Exploring Career Paths in GPCR Research with Dr. Jacek Mokrosiński | Dr. GPCR Ecosystem
mechanism through which rare genetic variation may lead to or protecting from excessive body weight gain Yamina will schedule a future talk with Jacek about GPCRs as therapeutic modalities. The discussion revealed their interest in GPCRs as therapeutic modalities and possible future collaborations
- Dr. Nariman Balenga | Dr. GPCR Ecosystem
the role of RGS4 and RGS5 in airway hyperresponsiveness and lung fibrosis in acute and chronic mouse models A fungal serine protease allergen with GPCR-modulating features was discovered as a new biomarker and
- Anything BUT GPCRs with Dr. Mikel Garcia-Marcos | Dr. GPCR Ecosystem
Mikel Garcia-Marcos "I was trained as a biochemist and molecular biologist during my Ph.D (2005) in Spain (biochemistry, cell biology, genetics) and experimental systems (purified proteins, cultured cells, model Garcia-Marcos's academic journey, which spans training in Spain, Belgium, and a postdoctoral fellowship
- Dr. Simone Prömel & Dr. Ines Liebscher | Dr. GPCR Ecosystem
There she focused on the different modes of action of Adhesion GPCRs and found that they do not only different signals on a molecular level and how these are translated into physiological functions in various model
- Ross Cheloha: Nanobody-GPCR Conjugates and the Engineering of Receptor Selectivity | Dr. GPCR Ecosystem
In this conversation, he describes how attaching a moderately active peptide to a receptor-targeted nanobody The working model is that the nanobody anchors the conjugate at the receptor surface, positioning the camelid nanobodies 25:45 The first nanobody-GPCR ligand conjugate and an unexpected 10,000-fold potency gain
- Dr. Lauren M. Slosky | Dr. GPCR Ecosystem
Slosky characterized a new class of β-arrestin biased allosteric modulators (BAMs) for the neurotensin Critically, these ligands reduce addiction-associated behaviors in animal models without the side effects
- Qing Fan: Inside the Architecture of Class C GPCRs | Dr. GPCR Ecosystem
each transmembrane bundle that appear to function as both structural anchors and negative allosteric modulators analysis of the GABA-B2-bound lipid site further suggested that lipid acts as a negative allosteric modulator allosteric sites within the transmembrane domain as a more targeted alternative: they offer receptor modulation inside each transmembrane bundle 12:55 - What the lipids actually do - structural components, allosteric modulation , and open questions 14:57 - Disease territory: epilepsy, spasticity, pain, addiction, and the limitations
- Sam Hoare: Receptor Residence Time and GPCR Data Analysis | Dr. GPCR Ecosystem
Sam Hoare brings a data analyst's perspective to GPCR pharmacology — one trained in allosteric modulation After a PhD on allosteric modulation of dopamine receptors in Philip Strange's UK lab and a postdoc at biotech and pharmaceutical clients on GPCR data analysis, receptor binding kinetics, and pharmacological modeling The underlying pharmacological theory, from operational models of agonism to allosteric binding equations Samuel Hoare Sam completed his Ph.D. in biochemistry, studying allosteric modulation of dopamine receptors
- David Gloriam: Orphan Receptors, GPCRDB, and the Data Revolution in GPCR Pharmacology | Dr. GPCR Ecosystem
The result was a structured group management model built around four specialized subgroups, each with 15 - subgroups, leadership training, and delegation 40:41 What excites Gloriam today - open science models
- Kari Johnson: mGlu2, Addiction, and the Brain Circuits Alcohol Rewires | Dr. GPCR Ecosystem
By suppressing glutamate release across circuits in the basal ganglia, mGlu2 is positioned to modulate this receptor from the bench to the behaving animal, using optogenetics and circuit-selective mouse models Her lab investigates how GPCRs modulate synaptic transmission in brain circuits involved in reinforcement It is also a complication: a receptor that modulates so many circuits will inevitably produce wanted modulomics - studying circuit-specific GPCR function in the basal ganglia 20:45 Operant behavioral models
- Receptor Signaling Bias: A Valuable and Accessible Property of New Drug Candidates | Dr. GPCR Ecosystem
masterclasses with leading researchers Structured networking for scientists and biotech professionals Nonprofit model
- Robert J. Lefkowitz: Beta-Adrenergic Receptors, the GPCR Family, and Fifty Years of Discovery | Dr. GPCR Ecosystem
His research established the beta-2 adrenergic receptor as the primary model system for understanding Beta-adrenergic receptors as a model system — Why the adrenergic system, with its rich pharmacological
- Scaling GLP 1 Receptor Tools Through Academia Industry Collaboration | Dr. GPCR Ecosystem
validation in GPCR assay design Building reagents that must work in complex tissues, not just simplified models chemistry from the University of Bari in 2018, including research training at the CIQUS Research Center in Spain Her work centers on GPCR modulators, synthetic chemistry, and enabling robust biological assays through
- Univeristy Lecturers Details | Dr. GPCR Ecosystem
. 🌟 By teaching with us, you gain: ✔ Premium Membership for you and your team for one year (no credit Course details – title, format (short talk / mini-course / series), audience, main objectives, expected after submission). 🧱 Step 2: Plan Your Course Structure Decide how your course will flow — number of modules
- Dr. Graeme Milligan | Dr. GPCR Ecosystem
His main research group centers on the function, structure, and regulation of G protein-coupled receptors
- The Practical Assessment of Signaling Bias | Dr. GPCR Ecosystem
📌 Measuring Bias: A Quantitative Approach 🔹 The operational model provides a structured way to measure
- Murat Tunaboylu & Ben Holland | Dr. GPCR Ecosystem
GPCR About Ben Holland "Ben gained his masters in Engineering Science from Oxford, taking a specialisation
- GPCR Masterclass: Advanced Pharmacology & Drug Discovery | Dr. GPCR
Jacobson, Matteo Pavan Structure-Based Design of Modulators of Purinergic GPCRs <p class="font_8">Watch Matteo Pavan NIH Computational Chemist Driving Structure-Based Drug Discovery | Molecular Modeling | Innovation & Strategic Application Innovation & Strategic Application Pharmacology Foundations Allosteric Modulation & Kinetics Allosteric Modulation & Kinetics How it works? Each session begins with a focused presentation from the guest expert, followed by moderated discussion
- Silvio Gutkind: Building a Lab That Doesn't Shut Down | Dr. GPCR Ecosystem
Gutkind a pre-built mental model for what to freeze, what to protect, and what to let continue.
- Dr. Sudarshan Rajagopal | Dr. GPCR Ecosystem
The main focus of his lab’s research is on the mechanisms underlying biased agonism at chemokine receptors
- Dr. Timo De Groof | Dr. GPCR Ecosystem
During his last year of studies, Timo performed research in the biopharmaceutical company Argen X and gained
- Joseph Kim: Structural Biology and Drug Discovery at GPCRs | Dr. GPCR Ecosystem
Listeners will gain insight into the scientific reasoning behind GPCR structural studies, the evolving New Tools Enable Re-exploring Old Questions Advances in cryo-EM, computational modeling, and machine That unusual binding mode might explain why it has been so difficult to identify small-molecule ligands Yamina Berchiche: Unless you start thinking about allosteric modulators. Dr. Joseph Kim: Right—and once you start thinking about allosteric modulation, you open an entirely new set
- Dr. Prasenjit Saha | Dr. GPCR Ecosystem
More recently, I have shifted my focus to identifying allosteric modulators of host G-protein-coupled However, the pursuit of allosteric modulators has gained attention as they have the potential to fine-tune



























